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ABSTRACT 
Objective: There is a lot of information about cancer in Electronic Health Record (EHR) notes 
that can be useful for biomedical research provided natural language processing (NLP) methods 
are available to extract and structure this information. In this paper, we present a scoping review 
of existing clinical NLP literature for cancer.  
Methods: We identified studies describing an NLP method to extract specific cancer-related 
information from EHR sources from PubMed, Google Scholar, ACL Anthology, and existing 
reviews. Two exclusion criteria were used in this study. We excluded articles where the 
extraction techniques used were too broad to be represented as frames (e.g., document 
classification) and also where very low-level extraction methods were used (e.g. simply 
identifying clinical concepts). 79 articles were included in the final review. We organized this 
information according to frame semantic principles to help identify common areas of overlap and 
potential gaps. 
Results: Frames were created from the reviewed articles pertaining to cancer information such as 
cancer diagnosis, tumor description, cancer procedure, breast cancer diagnosis, prostate cancer 
diagnosis and pain in prostate cancer patients. These frames included both a definition as well as 
specific frame elements (i.e. extractable attributes). We found that cancer diagnosis was the most 
common frame among the reviewed papers (36 out of 79), with recent work focusing on 
extracting information related to treatment and breast cancer diagnosis. 
Conclusion: The list of common frames described in this paper identifies important cancer-
related information extracted by existing NLP techniques and serves as a useful resource for 
future researchers requiring cancer information extracted from EHR notes. We also argue, due to 
the heavy duplication of cancer NLP systems, that a general purpose resource of annotated 
cancer frames and corresponding NLP tools would be valuable. 
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INTRODUCTION 
Unstructured clinical data about cancer patients is increasingly available in clinical notes in 
Electronic Health Records (EHRs) and other systems. There is increasing interest in utilizing this 
data for biomedical research [1][2] [3][4][5][6][7][8]. Furthermore, with the emergence of 
precision medicine, the need to extract more and more detailed information from a patient’s EHR 
notes becomes ever greater. Many publications argue for the need to capture important clinical 
information on cancer, ranging from information about tissue specimens [9] to disease-related 
and outcome information [10], thus facilitating translational research by associating molecular 
information with disease phenotype [11]. Many of these information types are found nearly 
exclusively in unstructured or semi-structured format in EHRs. For example, information 
associated with biomarkers and cancer prognosis are frequently stored in free-text surgical 
pathology reports [12]. Some work focuses on extracting information to improve cancer 
screening efficiency [1] [7][13][14][15]. All such work has focused on deriving cancer-related 
information automatically using various natural language processing (NLP) techniques. 
Although a majority of the methods applying deep learning in cancer research are for processing 
images (e.g. mammograms) [16][17][18][19] and gene expression profiles [20][21][22], more 
recently, deep-learning based NLP systems are gaining prominence for cancer information 
extraction from EHRs [23][24][25] [26][27]. For example, Gao et al. [26] implemented a 
hierarchical attention network for extracting some of the crucial clinical oncology data elements 
such as primary cancer site and histological grade which are gathered by cancer registries. 
 
However, many of these researchers put sizable effort into designing and implementing NLP 
systems that extract similar information types. In this scoping review, we investigate which 
cancer information types have been extracted with NLP techniques. We organize the extracted 
information into frames, based on the linguistic theory of ‘frame semantics’. Frames provide a 
convenient, flexible, and linguistically-motivated representation for information as complex and 
diverse as that related to cancer. Our aim is to provide a list of cancer-related frames in existing 
work that would be valuable to the scientific community. 
 
Frame semantics is a linguistic theory that postulates the meaning of most words is understood in 
relation to a conceptual frame in which entities take part. E.g., the meaning of sell in the “Jerry 
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sold a car to Chuck” evokes a frame related to COMMERCE, which includes four elements: 
BUYER, SELLER, MONEY, and GOODS, though not all elements are required (as with 
MONEY here). Frames can represent all events types, from the simple PLACING frame (“Maria 
put money in her account”) with elements AGENT, THEME, and GOAL, to the more complex 
HIRING (“He hired Downing as his coach in Hawai'i”) with elements EMPLOYER, 
EMPLOYEE, POSITION, and PLACE. Frames can also encode relations (e.g., KINSHIP: 
“Joe’s brother John”) and states (e.g., BEING_IN_OPERATION: “the centrifuge is 
operational”). Currently, the Berkeley FrameNet database [28] contains more than 1,200 frames 
with an average of about 10 elements per frame. Manual annotations of more than 200,000 frame 
instances provide a unique level of detail about how these elements can appear in sentences. The 
frames are connected by more than 1,800 frame relations, forming a lattice structure. As 
exemplified by the above examples, however, FrameNet has minimal coverage of biomedical 
information. This review may be viewed, then, as part of a proposed set of frames specifically 
targeting cancer information in EHR notes. On the other hand, frame semantics simply provides 
a useful mechanism for organizing the wide variety of information found in the papers covered 
by this review. We make no claim these frames are the ‘best’ way to organize cancer information 
for non-NLP purposes. These frames are, however, a natural endpoint for a scoping review, as 
they help to succinctly define the scope of cancer information that has been extracted from EHR 
free text. 
 
MATERIALS AND METHODS 
The goal of this study is to review papers on NLP for EHR notes related to cancer, determine 
what (parts of) frame(s) the researchers aim to extract, then express the complete set of frames in 
a consistent way across all the identified papers. The focus is thus the type of cancer data that is 
extracted using NLP, rather than on the NLP method used or its performance. PubMed and 
Google Scholar were searched using the keywords ‘natural language processing’ or ‘NLP’ 
anywhere in the article and one of the three keywords from ‘cancer’, ‘tumor’, and ‘oncology’ in 
the title. We also searched the ACL Anthology using only the cancer related keywords (‘cancer’, 
‘tumor’, or ‘oncology’) in the title. Results were limited to papers published after January 1, 
2000 in order to capture the current generation of statistical and machine learning-based NLP 
(though we did not exclude articles after this date based on method). Additionally, citations from 
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two cancer NLP reviews [29][30] were used. Finally, relevant citations in the reviewed papers 
were iteratively added to the review process.  
 
We obtained a total of 899 articles using the above search process (108 via PubMed, 738 via 
Google Scholar, 16 via ACL Anthology, and 37 via the existing reviews).  After de-duplication, 
703 articles were chosen for title/abstract screening.  
 
Screening Process 
We selected relevant articles based on whether the title or abstract contained the description of 
an NLP method to extract cancer-related information from EHR notes, or suggests cancer-related 
information is extracted from free text EHR sources. Two raters (SD, KR) independently 
assessed whether the title or abstract suggested that the data source was not related to EHR notes 
(e.g., literature [31], social media [32][33]). Papers describing NLP on data sources other than 
EHR notes were excluded. If the data source was not clear, or the raters could not agree during 
reconciliation, the paper was kept for full-text review.  
 
For the 173 papers that passed the initial title/abstract screening, two further exclusion criteria 
were applied to the full text. First, document-level text classification methods were excluded. 
Not only are these not considered information extraction NLP methods and are not amenable to 
frame representation, they are often application specific and not re-purposable. For example, an 
article by Garla et al. [34] describing a binary classifier to determine whether a clinical report is 
about a potential malignant liver lesion requiring follow up would not be considered for this 
study. This is a very common use case of NLP for cancer research, but these methods do not 
attempt to identify specific cancer-related data elements, and are thus not amenable to frames. 
On the other hand, an article that extracts references to malignant liver lesions and factors (e.g., 
phrases) that may impact the need for follow up would be relevant for this study since those 
factors could be organized by frame. Second, articles were excluded where very unspecific 
extraction methods were used like concept recognition and named entity recognition techniques 
(such as the use of MetaMap [35] or cTAKES [36]) that identify phrases but do not attempt to 
connect these to their wider context [37][38][39]. For example, an article by Xie et al. [39] that 
does not differentiate between an asserted and a negated concept, such as extracting the phrase 
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“breast cancer” regardless of the context being “has breast cancer” vs. “has no breast cancer”, is 
not sufficiently semantically expressive and would thus be excluded. Similarly, an article 
describing the use of a general-purpose concept extraction tool on mammography reports would 
not be considered relevant for frame representation. These types of NLP articles can be viewed 
as describing the basic building blocks upon which a frame-based information extraction system 
can be built, but they do not capture sufficient contextual information to be properly described as 
frames. In cases where the exclusion decision could not be made from the title and abstract 
alone, the full text was screened. In total, title/abstract screening resulted in removing 530 
articles and the full-text review of the remaining 173 articles eliminated a further 94 articles. 
Finally 79 articles were included in this scoping review.  Figure 1 shows the overall process 
including numbers removed at each stage. 
 
Frame Construction 
For each of the 79 articles relevant to frame semantics for cancer in EHR notes, one or more 
frames were constructed to represent the information types extracted by the described NLP 
system. Note that NLP systems are not typically described in a frame semantic manner nor use 
the terminology of frames. Instead, this had to be inferred based on the descriptions. For papers 
that focus on one or two data types, this is a straightforward process that results in a single, small 
frame description or a single element within a larger frame. For papers that focus on multiple 
data types (at least 7 papers describe over 5 different data types), the data types were organized 
into one or more frames. Multiple frames were used when the information was conceptually 
different (e.g., the description of a tumor versus the description of a cancer procedure). However, 
this was an iterative, collaborative process: batches of 20 papers were considered at a time, and 
two reviewers proposed initial frames for each of the papers. Disagreements were reconciled, 
after which the next batch was considered, which may have resulted in new frames as well as 
modifications to frames created in previous batches. A common set of frames was created that 
described important cancer-related information that NLP techniques have been used to extract.  
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Figure 1: PRISMA diagram for study selection  
 
RESULTS 
Frame Descriptions 
Each constructed frame has a name along with a definition (see Figure 2). Moreover, each frame 
is described using some attributes or elements, known as ‘frame elements’. The frame elements 
correspond to the specific items extracted by one or more NLP system included in this study. 
Each of these elements is defined briefly along with identifying the corresponding articles that 
extract that frame element (Table 1). For example, ‘CANCER DIAGNOSIS’ is a frame, which is 
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defined as ‘an event of a patient being diagnosed with a cancer’, and described using frame 
elements such as ANATOMICAL SITE, HISTOLOGY, and DIAGNOSIS STATUS. 
 
Frame Relations 
The constructed frames additionally have relations between them based on those found in 
Berkeley FrameNet [28]. First is the ‘parent-child’ or ‘inheritance’ relation (‘inherits’ in Figure 
2). More specifically, every child frame is a specific version of the parent frame. For example, 
‘CANCER DIAGNOSIS’ frame is inherited by multiple frames such as ‘BREAST CANCER 
DIAGNOSIS’ and ‘BLADDER CANCER DIAGNOSIS’. The elements in ‘CANCER 
DIAGNOSIS’ frame are generic to diagnosis of any cancer type, whereas ‘BREAST CANCER 
DIAGNOSIS’ frame contains extra breast cancer-specific elements such as RECEPTOR STATUS 
and RECEPTOR PERCENT. Similarly, an element such as MUSCULARIS PROPRIA is more prevalent 
in bladder cancer diagnosis cases. 
 
The second relation is ‘an element of’ where a frame is an element described in another frame. 
This is analogous to the ‘Subframe’ relation proposed in the Berkeley FrameNet project. As 
mentioned in Table 1, TNM CLASSIFICATION is an element present in both ‘CANCER 
DIAGNOSIS’ and ‘TUMOR DESCRIPTION’ frames, while at the same time, ‘TNM 
CLASSIFICATION’ is described as a separate frame altogether. A separate frame for a frame 
element was created if the element has multiple attributes and at least one included paper extracts 
such attributes. For example, AAlAbdulsalam et al. [2] extracts elements which are very specific 
to TNM stage such as the actual stage designation (e.g. T1, N1b), staging method (e.g. clinical or 
pathological staging), and negation. This information can be better understood if a separate 
frame ‘TNM CLASSIFICATION’ is created to contain TNM staging related details. 
 
The third frame relation is ‘associated with’, which indicates any kind of association or 
dependency between two frames. For example, the ‘CANCER FINDING’ frame is associated 
with the ‘THERAPEUTIC PROCEDURE’ frame as the findings in clinical reports often aid in 
selecting the best therapy for treating cancer patients. 
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Although existing work extracted cancer information for numerous cancer types, we only created 
child frames for those types where any type-specific information was extracted. There were 
papers related to cancer types such as lung cancer [40][41], liver cancer [42] and ovarian cancer 
[43], but no frames were created for these types as they all extract the general cancer-related 
elements described in the ‘CANCER DIAGNOSIS’ frame. 
 
Table 1 summarizes the frames created from the 79 selected papers, with corresponding per-
element references. Supplementary Table 1 lists the per-frame references. The frame descriptions 
and the overall relationships between the frames are shown in Figure 2. 
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Table 1: Frames (including frame elements) along with the associated articles 
Frame Frame Elements References 
CANCER 
DIAGNOSIS 
NAME: cancer type [44], [45], [42], [46], [47], [48], [49], [50], [51] 
ANATOMICAL SITE: the location 
description of the finding (including 
primary and metastatic sites) 
[45], [52], [42], [53], [54], 
[55], [25], [27], [56], [57] 
HISTOLOGY: histological description 
(e.g. carcinoma) 
[44], [52], [58], [55], [53], 
[54], [4], [27], [59], [43], 
[57] 
GRADE: appearance of the cancerous 
cells, can be frame with further 
information (GRADING VALUE) 
[44], [52], [54], [4], [48], 
[27], [59], [60], [43], [61], 
[62] 
INVASION TYPE: the stage or level of 
invasion 
[52] 
TUMOR BLOCK: tissue cores removed 
from regions of interest in paraffin-
embedded tissues (e.g. 0.6 mm in 
diameter) 
[52] 
TISSUE BANK: identifiers about location 
of tissue samples within an institution 
[52] 
STATUS: whether confirmed, suspected 
and there is no evidence of finding (e.g. 
probable, definite, without) 
[42], [57] 
RECURRENT STATUS: the value of 
recurrent status 
[42], [63], [57] 
TEMPORAL INFORMATION: refers to 
information about time (e.g., year, 
month, and date, 2007-08-04) 
[42], [57] 
SPECIMEN TYPE: the type of specimen 
involved in diagnosis  
[53] 
LATERALITY: describes the side of a 
paired organ associated with origin of 
the primary cancer 
[53], [54], [25], [48], [64], 
[27], [51] 
TUMOR SIZE: how large across the 
tumor is at its widest point (part of 
cancer staging) 
[52], [53], [54], [25], [48], 
[65], [59], [60], [62], [57] 
TNM STAGE: cancer staging system, can 
be a separate frame with further 
information (TNM 
CLASSIFICATION) 
[55], [53], [2], [3], [25], 
[66], [67], [60], [50], [40], 
[61] 
EXTENSION: direct extension of tumor [53] 
UNCERTAINTY: used to differentiate 
clinical suspicions from conclusive 
findings (e.g., possible, likely) 
[68], [57] 
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Frame Frame Elements References 
NEGATION: existence/negation of 
diagnosis (e.g., no, positive) 
[68], [57] 
DISEASE: disease related concepts 
related to diagnosis (disease stage and 
severity) 
[11], [25] 
DISEASE EXTENT: determine extent of 
disease (e.g., non-invasive, invasive, or 
metastatic) 
[68], [69], [57] 
STAGE: the overall stage of cancer (e.g. 
Stage 0, Stage I) 
[70], [52], [42], [54], [25], 
[69], [40], [43], [61], [57] 
EXISTENCE: existence description of the 
finding 
[45] 
TEMPORAL MODIFIER: temporal 
modifiers of the finding 
[45] 
ASSOCIATION: associations with other 
findings (may or may not be related to 
cancer) (e.g. causal, differential 
interpretation, and co-occurring) 
[45] 
BREAST CANCER 
DIAGNOSIS 
STATUS OF CANCER TYPES: presence  
or absence of various types of breast 
cancer (e.g. ductal carcinoma in situ, 
invasive lobular carcinoma, atypia) 
[47], [64], [49], [65], [24] 
RECEPTOR  NAME: estrogen, 
progesterone, human epidermal growth 
factor 2 
[71], [72], [25] 
RECEPTOR STATUS: positive/negative [72], [48], [66], [64], [69], [65], [60] 
RECEPTOR STATUS NEGATION: negation 
of  status  from surrounding text of 
receptor status mention 
[72] 
RECEPTOR PERCENT: number of cells 
out of 100 that stained positive for a 
receptor 
[48], [60] 
EXTRACAPSULAR AXILLARY NODAL 
EXTENSION STATUS: presence/absence 
of extracapsular extension in axillary 
lymph nodes 
[64] 
ISOLATED CANCER CELLS IN LYMPH 
NODES STATUS: presence/absence of 
isolated cancer cells in sentinel lymph 
nodes 
[64] 
MENOPAUSAL STATUS: status of 
menopause 
[69] 
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Frame Frame Elements References 
SCARFF-BLOOM-RICHARDSON (SBR) 
STAGE -prognostic factor in breast 
cancer, associated with cell 
proliferation, also a consistent indicator 
of response to chemotherapy 
[65] 
CONTRALATERAL EVENT: event of 
detecting a tumor in the opposite breast 
which was diagnosed more than 6 
months following the detection of the 
first cancer 
[51] 
MEDIASTINAL AND/OR STERNAL 
INVOLVEMENT: metastatic to sternum 
or mediastinum 
[73] 
COLORECTAL 
CANCER 
DIAGNOSIS 
POLYPS TYPE: type of polyp present at 
the time of colonoscopy procedure 
(e.g., advanced conventional 
adenomas) 
[59] 
BLADDER 
CANCER 
DIAGNOSIS 
INVASION STATUS: presence or absence 
of invasion 
[44], [58], [4] 
DEPTH OF INVASION: measured from 
the basement membrane of epithelium 
from which the tumor is considered to 
arise, to the deepest point of invasion 
(e.g., superficial and muscle invasion) 
[44], [58], [4], [50] 
MUSCULARIS PROPRIA: presence or 
absence of muscle in the specimen 
[44], [58], [4] 
CARCINOMA IN SITU: statements 
regarding presence of carcinoma in 
situ, a group of abnormal cells 
[58], [4], [67], [61] 
SKIN CANCER 
DIAGNOSIS 
CLARK LEVEL: described in separate 
frame (CLARK LEVEL) 
[5] 
BRESLOW DEPTH: described in separate 
frame (BRESLOW DEPTH) 
[5] 
PROSTATE 
CANCER 
DIAGNOSIS 
GLEASON SCORE: described in separate 
frame (GLEASON SCORE) 
[5], [68], [3] 
PSA: prostate-specific antigen value [3] 
COMORBIDITY 
DIAGNOSIS 
NAME: name of the comorbidity 
diagnosis (e.g. Liver cirrhosis) 
[42] 
DIAGNOSIS STATUS: Whether 
confirmed, suspected and there is no 
evidence of finding (e.g. probable, 
definite, without) 
[42] 
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Frame Frame Elements References 
CHILD-PUGH STAGING: e.g. Child-Pugh 
score: class A) 
[42] 
TEMPORAL INFORMATION: refers to 
information about time 
[42] 
REPORT TYPE: type of the report (e.g. 
Computed Tomography) 
[42] 
FAMILY HISTORY 
FAMILY MEMBER: associated member [74] 
DIAGNOSIS: associated cancer diagnosis [74] 
RELATION: Relation between the family 
member and diagnosis 
[74] 
NEGATION: negated mention of history [74] 
KI-67 EXPRESSION 
KI-67 SCORE:  a cancer antigen that is 
expressed during cell growth and 
division, but is absent in the cell resting 
phase 
[6], [75], [48], [65], [62] 
GRADING VALUE 
SCALE: cancer is usually graded on a 
scale of 1-3 (lower number indicates 
cancer cells look more similar to 
normal cells) 
[5], [52] 
TYPE: grading categories (e.g. Grade 1 
– well differentiated) 
[52], [54], [4], [43], [61] 
CLARK LEVEL 
VALUE: describes the level of 
anatomical invasion of the melanoma 
in the skin 
[5] 
BRESLOW DEPTH 
VALUE: the distance between the upper 
layer of the epidermis and the deepest 
point of tumor penetration 
[5] 
GLEASON SCORE 
SCORE: grading system used to 
determine the aggressiveness of 
prostate cancer 
[5], [68], [76] 
ASSESSMENT FOR 
PROSTATE 
CANCER 
SURGERY 
GLEASON SCORE: described in separate 
frame (GLEASON SCORE) 
[76] 
PRE-TREATMENT 
PROSTATE 
CANCER 
ASSESSMENT 
GLEASON SCORE: described in separate 
frame (GLEASON SCORE) 
[77] 
ASSESSMENT FOR 
CANCER 
SURGERY 
TNM STAGE: cancer staging system, a 
separate frame with further information 
(TNM CLASSIFICATION) 
[76] 
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Frame Frame Elements References 
MARGIN STATUS: status of surgical 
margin, described in separate frame 
(MARGIN) 
[76] 
PRE-TREATMENT 
CANCER 
ASSESSMENT 
DOCUMENTATION: documentation 
within 6 months prior to initial 
treatment (e.g. treatment of prostate-
specific antigen) 
[77] 
PROCEDURE: performing diagnostic 
test, described in frame (CANCER 
PROCEDURE) 
[77] 
MARGIN 
TYPE: type (e.g., anatomical, surgical) [52] 
STATE/STATUS: if the inked margin of 
resection is found to contain tumor, it 
indicates that the surgeon inadvertently 
incised into the tumor, resulting in a 
positive surgical margin (e.g. positive 
surgical margin, negative surgical 
margin, not applicable or no explicit 
diagnosis provided) 
[52], [76] 
DIMENSION: margin size [52] 
ASSESSMENT FOR 
CANCER CARE 
SURGERY RELATED: described in 
separate frame (ASSESSMENT FOR 
CANCER SURGERY) 
[76] 
PRE-TREATMENT RELATED: 
pretreatment process quality measures, 
described in frame (PRE-
TREATMENT CANCER 
ASSESSMENT) 
[77] 
PAIN IN 
PROSTATE 
CANCER 
PATIENTS 
MENTION: mention of pain related term [78] 
PAIN SEVERITY: associated with a 
severity level from the four-tiered pain 
scale (no pain - category 0; some pain - 
category 1; controlled pain - category 
2; severe pain - category 3) 
[78] 
INTERNAL DATES: pain start and end 
dates 
[78] 
LOCATION: body location of pain [78] 
NEGATION: negated mentions of pain 
related terms 
[78] 
CANCER 
PROCEDURE 
NAME: name of the procedure/test (e.g. 
chest x-ray) 
[6], [79], [80], [75], [71], 
[81], [15], [1], [9], [82], 
[83], [60], [50], [43] 
 15 
Frame Frame Elements References 
CODE TERMINOLOGY: clinical 
terminology used for the procedure 
mention 
[52] 
CODE VALUE: value of the terminology 
code [52], [1] 
INSTITUTION: institution where the 
procedure was performed [52] 
NEGATION: whether the mention is 
negated [52], [77] 
MENTION: words related to any 
procedure term (e.g. flex sig,  guaiac 
card) 
[75], [52], [15], [84], [77], 
[43] 
MARGIN: usually the rim of normal 
tissue taken removed during or after 
procedure (surgical margin) 
[52] 
ANATOMICAL SITE: part of body 
procedure targets (e.g., breast) [79], [52] 
TEMPORAL INFORMATION: time and 
date descriptors (e.g., “colonoscopy in 
2005”, “flexible sigmoidoscopy 5 years 
ago), date of completion 
[52], [15], [1], [10] 
STATUS: procedure or treatment status 
(e.g., refused, declined, scheduled, 
planned, completed, reported vs not 
reported) 
[15], [42], [1], [82] 
MODIFIER: negation and other 
modifiers that change the status of 
procedure (e.g., “no”, “never”) 
[15] 
TUMOR 
DESCRIPTION 
ANATOMICAL SITE: anatomic locations 
(e.g., “segment 5” or “left lobe”) with 
attributes (Liver, Non Liver), target 
location (e.g., liver and segment #7) as 
well as non-target location (e.g., breast) 
[13], [8], [52], [85], [42], 
[25], [9], [23], [26], [41] 
LATERALITY: side of a paired organ 
associated with origin of the primary 
tumor 
[25] 
TYPE: primary/metastatic [25] 
STATUS: benign or malignancy status 
along with diagnostic information such 
as ‘suggestive of cyst’ 
[85], [86], [41], [57] 
HISTOLOGY: morphologic type of the 
tumor 
[52], [9] 
STAGE: tumor stage [8], [68] 
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Frame Frame Elements References 
GRADE: appearance of the cancerous 
cells 
[8], [52], [9], [48], [87], 
[26] 
INVASION: whether or not more than 
50% of an organ is invaded 
[52], [88] 
SIZE: quantitative size of tumor (e.g., 
2.2 x 2.0 cm), diameter/volume of the 
tumor, including unit (e.g., 1 cm, 0.3 x 
0.5 x 0.7 cm) 
[13], [52], [88], [85], [42], 
[25], [48], [41] 
SIZE TYPE: radiological/pathological [25] 
NEGATION: indicator to some negation 
of a tumor reference (e.g., no) 
[85], [86], [41] 
COUNT: number of tumor/nodule 
references (e.g., two or multiple) 
[13], [88], [85] 
TUMOR REFERENCE: a radiologic 
artifact that may reference a tumor 
(e.g., lesion or focal density) 
[88], [85] 
MENTION: tumor major object (e.g., 
tumor, lesion, mass, and nodule) 
[13], [42], [47], [49], [41] 
QUANTIFIER: one, two, three, several [42] 
TEMPORAL INFORMATION: refers to 
information about time (e.g., year, 
month, and date, 2007-08-04) 
[52], [42], [86] 
NON-TUMOR SIZE ITEMS: LeVeen 
needle, which is used in RFA treatment 
[42] 
STATUS: this indicates the final overall 
tumor status (e.g., regression, stable, 
progression, irrelevant) 
[89], [41] 
METASTATIC STATUS INDICATORS: 
phrases denoting a metastatic tumor 
[9], [90] 
MAGNITUDE: indicates the qualitative 
extent of change, if any (e.g., mild, 
moderate, marked) 
[89] 
SIGNIFICANCE: indicates the subjective 
clinical significance of change, if any 
(e.g., uncertain, possible, probable) 
[89] 
TRACK ASSIGNMENT: Fleischner 
Society based surveillance track 
assignment for patients who received 
LCS LDCT (guidelines about follow-
up procedure depending on the nodule 
size) 
[13] 
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Frame Frame Elements References 
PROCEDURE: method for obtaining the 
tumor, can be a separate frame 
(CANCER PROCEDURE) 
[13], [9], [50] 
TNM STAGE: cancer staging system, a 
separate frame with further information 
(TNM CLASSIFICATION) 
[52], [87], [50] 
CLOCK-FACE: clock-face location of 
the tumor 
[25] 
BLADDER TUMOR  
DESCRIPTION 
MUSCLE INFORMATION: presence or 
absence of muscle, for those that 
mentioned muscle, rates of muscle 
presence in the surgical specimen 
[8], [87] 
CARCINOMA IN SITU: statements 
regarding presence of carcinoma in situ 
[87] 
CANCER 
TREATMENT 
TYPE: drug, procedure, radiation, etc. [25], [10], [43] 
PATIENT CENTERED OUTCOMES: 
outcomes as interpreted and 
documented by clinicians following a 
patient's cancer treatment along with 
their semantic context such as 
negations 
[91] 
PATIENT REPORTED OUTCOMES: 
symptoms experienced by patients 
during cancer treatment along with 
negations 
[92] 
SITE: metastatic site of cancer where 
the treatment was targeted 
[10] 
TNM 
CLASSIFICATION 
TUMOR SIZE: diameter/volume of the 
tumor, including unit (e.g., 3-4 mm) 
[6], [67], [60] 
REGIONAL LYMPH NODES INVOLVED: 
regional lymph nodes information used 
to detect staging 
[6], [93] 
METASTASIS: whether the tumor has 
invaded the nearby tissues 
[6], [50] 
DISTANT METASTASIS: whether tumor 
has spread from the original (primary) 
tumor to distant organs or distant 
lymph nodes 
[6], [93] 
GRADE: appearance of the cancerous 
cells 
[6], [67], [60] 
STAGING FACTORS: factors relevant to 
staging and used to calculate the TNM 
stage 
[93] 
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Frame Frame Elements References 
STAGE: AJCC stage designation (e.g., 
T1, N1b) 
[2], [3], [25], [66], [60], 
[50], [40], [61] 
TIMING: used to indicate if the staging 
is clinical or pathological as per the 
rules of the AJCC manual 
[2], [3], [25], [66], [50], 
[40] 
NEGATION:  any negated mention [2] 
TEMPORALITY: capture historical or 
future mentions that do not necessarily 
represent current mentions valid at the 
point in time when the mention was 
stated at the patient record 
[2] 
SUBJECT INVOLVED: capture TNM 
mentions related to family relatives or 
others 
[2] 
PERFORMANCE 
STATUS 
NAME: name of the performance status 
scale, used as a prognostic tool (e.g. 
ECOG, Karnofsky) 
[55], [40] 
SCORE: measure of functional status 
(ECOG score ranges from 0-5, whereas 
Karnofsky Scale' ranges from 0-100) 
[40] 
DIAGNOSTIC 
PROCEDURE 
PROCEDURE RESULT: result of a 
procedure mentioned in the report (e.g., 
Calcifications, hyperplasia etc.) 
[79] 
TEST RESULT: result of the test (e.g. 
positive vs negative) 
[14], [82], [94], [83], [77] 
THERAPEUTIC 
PROCEDURE 
TYPE: treatment type (e.g., RFA and 
TACE) 
[42], [60], [50] 
LINE OF THERAPY: initial treatment is 
referred to as first-line treatment or 
first-line therapy,  however, a second-
line treatment may be suggested later 
[50] 
THERAPY DOSE: the total about of 
treatment (e.g., radiation) the patient is 
exposed to (e.g. radiation therapy dose) 
[10] 
TOXICITIES: various toxicities related to 
cancer treatment therapy along with 
negation and certainty 
[10] 
CANCER FINDING 
PROCEDURE: name of the associated 
cancer procedure (e.g., Breast Core 
biopsy), can be a separate frame 
(CANCER PROCEDURE) 
[7], [79], [71], [81], [11] 
FINDING TYPE: type of the finding (e.g., 
negative, normal, positive, possible, 
 
[80] 
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Frame Frame Elements References 
probably, history, mild, stable, 
improved, or recommendation) 
FINDING MODIFIER: modifying words 
from within the report (e.g., type: mild, 
modifiers: tortuous) 
[80] 
LATERALITY: location or sidedness of 
the finding (e.g., “left”, “right,” "both", 
or “bilateral”) 
[79] 
BODY PARTS: body organs on which 
the finding is reported 
[11] 
PATHOLOGY 
FINDING 
POSITIVE LYMPH NODES NUMBER: 
number of positive lymph nodes 
mentioned in the finding 
[71], [48], [65] 
POSITIVE LYMPH NODES STATUS: 
presence or absence of positive lymph 
nodes 
[64] 
LYMPH NODES REMOVED: number of 
lymph nodes removed 
[48] 
NUCLEAR GRADE: describes how 
closely the nuclei of cancer cells look 
like the nuclei of normal cells 
[71] 
PLOIDY: refers to amount of DNA the 
cancer cells contain 
[71] 
QUALITATIVE S-PHASE: indicator of 
tumor growth rate 
[71] 
BIOMARKER: name of the biomarker [12], [40] 
BIOMARKER TEST RESULTS / MUTATION 
STATUS: positive or negative for 
biomarkers such as ALK and EGFR 
[12], [40], [55], [65] 
SPECIMEN: specimens on which 
findings are described (e.g. core 
biopsies or organ portions) 
[66] 
STATUS OF INVASION: presence or 
absence of invasion such as blood 
vessel invasion) 
[64] 
IMAGING 
FINDING 
CALCIFICATION: presence or absence of 
calcification 
[7], [95], [96], [24] 
MASS: presence or absence of mass [7], [96], [24]  
ARCHITECTURAL DISTORTION: whether 
architectural distortion is present or 
absent 
[7], [96], [24] 
CYSTS: whether cyst is present or 
absent 
[7], [95] 
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Frame Frame Elements References 
NME: whether non-mass enhancement 
is present or absent 
[7] 
FOCUS: whether focus is present or not 
in imaging such as breast magnetic 
resonance imaging 
[7] 
RECOMMENDATION: follow-up 
recommendation 
[81] 
CALCIFICATION CHARACTERISTICS: 
characteristics of calcification 
[96] 
MUTATION CHARACTERISTICS: imaging 
descriptors/features to distinguish wild-
type vs mutated patients (e.g. 
distinguish wild-type and KRAS 
mutations) 
[97] 
BREAST IMAGING 
FINDING 
IMPLANTS: whether breast implants are 
present or absent 
[7] 
ASYMMETRY: whether asymmetry is 
present or absent 
[7], [96], [24] 
BIRADS CATEGORY: refers to the 
number stated for each breast and 
laterality (e.g. 1 for negative category) 
[7], [81] 
DENSITY: breast density or breast 
composition 
[96], [24] 
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Figure 2: Frames and their relations as expressed in literature 
 
Most Extracted Frames: 
As demonstrated in Table 1, ‘CANCER DIAGNOSIS’ is the most referenced frame overall, i.e. 
it has the highest number of associated articles (n=36). This was expected as most efforts focused 
on extracting general information related to diagnosis of cancer. However, this does not 
necessarily mean that a paper included in 'CANCER DIAGNOSIS' frame extracted all the 
elements present in that frame. We observe that a subset of papers extracting some specific 
elements of this frame also extracted elements present in one of its child frames. For instance, a 
breast cancer related article by Breischneider et al. [60] extracted general cancer data elements 
such as TNM CLASSIFICATION and GRADE present in ‘CANCER DIAGNOSIS’ frame whereas it 
also extracted RECEPTOR STATUS and RECEPTOR PERCENT elements described in the ‘BREAST 
CANCER DIAGNOSIS’ frame. Thus, some papers extract only a subset of elements present in 
one or more frames and not all of the elements related to a single frame. In terms of the total 
number of articles associated with a frame, the ‘CANCER DIAGNOSIS’ frame is followed by 
‘TUMOR DESCRIPTION’ (n=21) and CANCER PROCEDURE’ (n=19) frames. 
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Most Extracted Frame Elements 
We also note the distribution of papers at the frame element level. This provides an idea about 
the important clinical attributes found in EHR text related to cancer that interest researchers. 
Table 2 highlights the 10 most extracted frame elements along with the number of referenced 
articles. 
 
Table 2: Most extracted frame elements along with the number of referenced articles 
Frame Element Number of articles extracting this element 
GRADE 19 
ANATOMICAL SITE 18 
TUMOR SIZE 17 
TNM CLASSIFICATION 16 
CANCER PROCEDURE NAME 16 
STAGE RELATED (Overall + TNM) 15 
RECEPTOR/BIOMARKER RELATED 13 
HISTOLOGY 13 
STATUS (tumor and cancer related) 9 
LATERALITY 8 
 
Papers Extracting Multiple Frames 
Many eligible papers extracted varied types of cancer information corresponding to different 
frames. The NLP system developed by Savova et al. [25] extracted various cancer phenotypes 
from EHRs, which were then used to generate summaries containing both cancer and tumor 
characteristics. A similar trend was observed for other papers including [42] and [52], where 
information related to multiple frames were extracted. Notably, some frames (particularly the 
ones which are not directly associated) contain a few common elements. For example, TUMOR 
SIZE element is present in both ‘CANCER DIAGNOSIS’ and ‘TUMOR DESCRIPTION’ frames 
as size is one of the characteristics that can be associated with both tumor and cancer diagnosis 
(cancer being linked to tumor and tumor characteristics). Thus, assigning any paper to such a 
common frame element (e.g., TUMOR SIZE) was primarily based upon whether the paper dealt 
specifically with tumor description or cancer diagnosis. Table 3 shows a detailed overview of 
some of the noteworthy papers extracting information that could be represented using at least 
four different cancer frames.  
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Table 3: Papers extracting varied frames 
Paper Number of 
frames extracted 
Frames extracted Number of frame 
elements extracted 
Cary et al. [50] 6 CANCER 
DIAGNOSIS, 
BLADDER CANCER 
DIAGNOSIS, TNM 
CLASSIFICATION, 
TUMOR 
DESCRIPTION, 
CANCER 
PROCEDURE, 
THERAPEUTIC 
PROCEDURE 
11 
Napolitano et al. [5] 6 PROSTATE CANCER 
DIAGNOSIS, SKIN 
CANCER 
DIAGNOSIS, 
GLEASON SCORE, 
GRADING VALUE, 
CLARK LEVEL, 
BRESLOW DEPTH 
7 
Coden et al. [52] 5 CANCER 
PROCEDURE, 
CANCER 
DIAGNOSIS, TUMOR 
DESCRIPTION, 
GRADING VALUE, 
MARGIN 
28 
Ping et al. [42] 5 CANCER 
PROCEDURE, 
THERAPEUTIC 
PROCEDURE, 
TUMOR 
DESCRIPTION, 
CANCER 
DIAGNOSIS, 
COMORBIDITY 
DIAGNOSIS 
19 
Savova et al. [25] 5 TUMOR 
DESCRIPTION, 
CANCER 
TREATMENT, 
CANCER 
DIAGNOSIS, BREAST 
CANCER 
16 
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Paper Number of 
frames extracted 
Frames extracted Number of frame 
elements extracted 
DIAGNOSIS, TNM 
CLASSIFICATION 
Tang et al. [48] 5 CANCER 
DIAGNOSIS, BREAST 
CANCER 
DIAGNOSIS, 
PATHOLOGY 
FINDING, KI-67 
EXPRESSION, 
TUMOR 
DESCRIPTION 
11 
Breischneider et al. 
[60] 
5 CANCER 
DIAGNOSIS, BREAST 
CANCER 
DIAGNOSIS, TNM 
CLASSIFICATION, 
CANCER 
PROCEDURE, 
THERAPEUTIC 
PROCEDURE 
10 
Xu et al. [71] 4 CANCER FINDING, 
PATHOLOGY 
FINDING, CANCER 
PROCEDURE, 
BREAST CANCER 
DIAGNOSIS 
7 
Thiebaut et al. [65] 4 CANCER 
DIAGNOSIS, BREAST 
CANCER 
DIAGNOSIS, KI-67 
EXPRESSION, 
PATHOLOGY 
FINDING 
7 
Schroeck et al. [61] 4 CANCER 
DIAGNOSIS, 
BLADDER CANCER 
DIAGNOSIS, TNM 
CLASSIFICATION, 
GRADING VALUE 
6 
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Significant Cancer Types Based on Elements Extracted 
Although a large proportion of the papers reviewed extracted general cancer information from 
EHRs using NLP, there are some papers which focused on extracting cancer-type specific 
information. The most notable cancer type was breast cancer, with the highest number of 
associated articles (n=14), followed by bladder cancer (n=6) and prostate cancer (n=4). 
 
The frame elements for the three most commonly extracted cancer types based on the number of 
articles are summarized in Table 4. There may be more articles related to each of these cancer 
types, but the number here includes those that extract only type specific information (e.g., 
information specific to breast cancer instead of general cancer information extracted only from 
the notes of breast cancer patients). 
 
 
Table 4: Most extracted cancer types 
Cancer type Important frame elements 
specific to this cancer 
Number of associated 
papers 
Breast Cancer STATUS OF CANCER TYPES, 
RECEPTOR NAME (mainly 
Estrogen, progesterone, 
human epidermal growth 
factor 2), RECEPTOR STATUS, 
RECEPTOR PERCENT, 
RECEPTOR STATUS 
NEGATION, SCARFF-BLOOM-
RICHARDSON STAGE, 
CONTRALATERAL EVENT 
14 
Bladder Cancer INVASION STATUS, DEPTH OF 
INVASION, MUSCULARIS 
PROPRIA, CARCINOMA IN SITU 
6 
Prostate Cancer GLEASON SCORE, PSA 4 
 
 
We also note in Table 1 that the ‘PROSTATE CANCER DIAGNOSIS’ frame has been 
associated with ‘PAIN IN PROSTATE CANCER PATIENTS’ frame, all of whose elements 
were extracted from clinical text in a case of metastatic prostate cancer patients for identifying 
unknown pain phenotypes [78]. Napolitano et al. [5] extracted ‘BRESLOW DEPTH’ and 
‘CLARK LEVEL’, both of which are grading values for skin cancer, as well as ‘GLEASON 
SCORE’ from pathology reports. 
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Frames Related to Cancer Quality Measures 
A few papers focused on automatically identifying quality measures information for assessing 
the handling of cancer patients such as grouping patients for clinical trials and making decisions 
about their treatment plans. The frames created for these quality measures, however, are general-
purpose (largely different types of patient assessments) and could be used for other applications 
as well. D’avolio et al. [76] specifically worked on extracting such measures like MARGIN 
STATUS for patients who underwent prostatectomies. Another paper by Hernandez-Boussard et 
al. [77] extracted information about pre-treatment quality metrics. In context to assessing quality 
for cancer care, the frame ‘ASSESSMENT FOR CANCER CARE’ contains two elements, 
ASSESSMENT FOR SURGERY and PRE-TREATMENT CANCER ASSESSMENT, each of which further 
describe their individual elements (shown in Table 1). We observe in the table that besides 
GLEASON SCORE and surgical MARGIN STATUS which is already stated above, ‘TNM 
CLASSIFICATION’ is also identified by the College of American Pathologists (CAP) as one of 
the three Category I measures [76] for assessing quality. 
 
Frames Related to Cancer Screening 
Some articles applied NLP techniques to extract colonoscopy testing or colorectal cancer (CRC) 
screening related information such as test MENTION, TEMPORAL INFORMATION (e.g. 
‘colonoscopy in 2005’), STATUS (e.g. ‘refused’, ‘scheduled’) and NEGATION (e.g., negation 
modifiers such as ‘no’ and ‘never’) of the tests [14][15][1]. Since the screening tests facilitate the 
cancer diagnosis process, we have represented the information using the ‘DIAGNOSTIC 
PROCEDURE’ frame (Table 1), which inherits from the ‘CANCER PROCEDURE’ frame 
(Figure 2). 
 
Another study by Ritzwoller et al. [13] extracted general characteristics of lung nodules (e.g. 
nodule size) from radiology reports that the providers submitted to a Centers for Medicare and 
Medicaid Services (CMS)-approved registry following any Low-Dose CT Lung cancer screening 
procedure. As represented in Table 1, all nodule related information are captured in the 
‘TUMOR DESCRIPTION’ frame. 
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Frames Related to Image Findings 
While a majority of papers identified information from pathology findings (which usually 
contain detailed tumor-related information), a few studies attempted to automatically extract data 
elements from imaging findings (e.g. mammography reports) [7][81][96][24]. Interestingly, 
these findings were mostly related to breast cancer screening. For example, Lacson et al. [7] 
extracted elements such as CALCIFICATION, MASS, IMPLANTS, BIRADS CATEGORY, CYSTS, etc. 
with the aim to use these extracted elements for populating a breast cancer screening registry. He 
et al. [24] employed deep learning and NLP methods to extract similar information such as 
BREAST DENSITY, MASS, ARCHITECTURAL DISTORTION etc. from mammographic findings for 
identifying high risk patients and patients for whom biopsy is recommended. We have 
represented all the imaging related data elements in the ‘IMAGING FINDING’ frame and its 
subframe, ‘BREAST IMAGE FINDING’. 
 
Other Important Frame Elements 
Apart from the above mentioned frames and their respective elements, some of the other 
important data elements that multiple researchers (at least 3) were concerned about were: TEST 
RESULT in the ‘DIAGNOSTIC PROCEDURE’ frame [14][82][94][77]; TEMPORAL 
INFORMATION [15][42][1][10] and STATUS [15][42][1][82] in the ‘CANCER PROCEDURE’ 
frame; CALCIFICATION, MASS, ASYMMETRY, ARCHITECTURAL DISTORTION in the ‘IMAGING 
FINDING’ frame [7][96][24]; TYPE in the ‘THERAPEUTIC PROCEDURE’ frame [42][60][50]; 
and KI-67 SCORE in the ‘KI-67 EXPRESSION’ frame [6][75][48][65]. 
 
Two of the studies we reviewed extracted a patient’s performance status information. One such 
performance measure is the Eastern Cooperative Oncology Group (ECOG) Scale of Performance 
Status, extracted by Herath et al. [55] and Najafabadipour et al. [40], whereas Karnofsky 
measure was extracted additionally by Najafabadipour et al. [40] from clinical narratives. 
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DISCUSSION 
Our scoping review provides a detailed review of current research in the cancer information 
extraction domain from unstructured EHR sources using NLP. 173 papers were identified as 
relevant to clinical NLP for cancer. Of these, 79 were included in the frame structure (Table 1 
and Figure 2). Appropriate interpretation of cancer information extracted as frames requires 
context, specifically tying the frames to the data source (EHR free text notes, in our case). We 
found that many papers use non-EHR sources for extracting cancer information (e.g., from 
biomedical literature), and these likely would have had entirely different frame structures (e.g., 
less patient-focused, more general knowledge-focused, more genomic information). 
 
Our review demonstrates evidence of the growing interest among NLP researchers in 
automatically extracting cancer related information from clinical text. The following points 
synthesize our key findings: 
 
The first key finding is the redundancy of certain information types (e.g., 19 papers extracted 
cancer grade information). This speaks to a tremendous replication of effort in these areas (Table 
2), as state-of-the-art NLP systems require medium to large manually-annotated training sets to 
build high-performance machine learning models. Yet, as far as we can tell, the papers describe 
systems developed exclusively on local data and do not involve the sharing of data or models, 
forcing future researchers and clinicians in need of these cancer information types to “reinvent 
the wheel”, replicating a time-consuming process requiring substantial NLP expertise. Pilot 
projects are underway to meet some of the needs of cancer researchers requiring such systems 
[25] [57], but the breadth of overlap (Table 1) suggests that without a more widely-available 
open resource, continued effort duplication will continue. Even more daunting are the cancer 
information needs that go unfulfilled because the costs of NLP projects are too high. This review 
demonstrates that there is a tremendous need for a more general-purpose cancer NLP resource. 
 
The second key finding is that, given the fact that so few papers focus on more than a few 
information types, the decision on which cancer types to extract for a project is clearly an ad hoc 
process. The genesis of most of these papers was the need to support a given research project or 
clinical use case. This leads, for example, to cancer-specific diagnostic information being 
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performed only for bladder, breast, colorectal, prostate, and skin cancer. Missing are common 
cancers such as lung cancer, lymphoma, kidney cancer, and leukemia. Each of these have 
information types specific to that form of cancer (e.g., certain blood tests for leukemia, or a 
blood marrow biopsy result). Given, again, the high effort and cost that can be associated with an 
NLP project, this collection of ad hoc projects—with both sizable overlap and yet key gaps—
would be better served by a more general-purpose effort. This effort would identify widely-
needed cancer information types and create an NLP system that supports a broad range of use 
cases. It would be impossible to cover all the use cases required by the 79 papers within this 
study, there are few specific, recurring information needs (Table 1). 
 
Impact of Frame Semantics 
This review organized cancer information according to the theory of frame semantics. As one 
can see from Figure 2, frames are an intuitive means of organizing information, not unlike entity-
relationship and class diagrams from computer science. Frame semantics, however, is a 
fundamentally linguistic theory, as already described. This largely helps to minimize 
discrepancies between possible frame representations, though we make no claim the one 
presented here is the only or ‘best’ method for representing cancer information. There are 
certainly no shortage of ontologies that already exist to describe cancer information. But given 
the prominence of frames in general NLP methods, it is nonetheless beneficial to consider what a 
set of frames for cancer would look like when targeted toward NLP for EHR notes. Further, we 
did not find evidence, during the course of this review, of any emerging standard for organizing 
information extracted by NLP for cancer. 
 
We consider this work, then, as the first step in an iterative process to derive an authoritative set 
of frames for cancer NLP targeted toward EHR notes. More investigation is certainly needed. 
Notably, frame structures need to stand up to the test of EHR text itself. Frame semantics asserts 
that the information (the elements) within a frame are often found together within some 
reasonable context (e.g., a cancer’s GRADE and ANATOMICAL SITE can be found within the same 
sentence, if not the same clause). So for the proposed frames, this needs to be tested for frames to 
be used as a definitive NLP target representation. 
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Regardless of the utility in the proposed frames for actual NLP development, the organization of 
this information into frame structures is nonetheless useful. Table 1 contains over 160 elements, 
and any attempt to describe all of these information types without some intermediate structure (a 
frame that contains some set of elements) would be difficult to interpret. For instance, if a future 
researcher were interested in several specific information types related to cancer therapy 
procedures, finding the ‘THERAPEUTIC PROCEDURE’ frame will allow access to papers 
related to the information types organized under this frame (e.g., THERAPY DOSE and TOXICITIES 
information). 
 
LIMITATIONS 
This work has several limitations. The first limitation of this review is that, given the rapid pace 
of NLP development and publication, it is likely that papers meeting inclusion criteria were 
omitted. Specifically, papers published starting in late 2018 were likely missed. Second, although 
we have tried to accurately interpret and represent all the possible information types extracted in 
the literature as frames, there might be a few which are not captured or mis-represented in our 
final frame list. Finally, as already discussed, there may be inconsistencies in assigning the 
frames and associated elements across all the papers. 
 
CONCLUSIONS 
Our scoping review provides a detailed overview of the current research in the cancer 
information extraction domain from unstructured EHR sources using NLP. We conducted the 
review from a frame semantic perspective, described various frames along with their elements as 
well as examined the relations between frames. Since many researchers are trying to extract 
similar frames or frame elements (though not always using the language of frame semantics), 
this review can help developers of a general-purpose cancer frame resource and NLP system that 
would extract a broad range of important cancer information types.  
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